Patent · US Active

Neuromodulatory methods for treating pulmonary disorders

US8155744B2 · kind B2 · utility

43Cited by
9References
15Claims
0Family size

Assignee

Inventor

Key dates

Filing dateDec 11, 2008
Grant dateApr 10, 2012
Priority date
Expiry dateMar 14, 2029

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61N1/3787
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

A method for treating a pulmonary disorder in a subject includes inserting a therapy delivery device into a vessel of the subject, advancing the therapy delivery device to a point adjacent an intraluminal target site of the autonomic nervous system, and activating the therapy delivery device to delivery a therapy signal to the intraluminal target site to treat the pulmonary disorder. The intraluminal target site is in electrical communication with nervous tissue selected from the group consisting of a spinal nerve, a postganglionic fiber of a spinal nerve, a sympathetic chain ganglion, a thoracic sympathetic chain ganglion, a cervical ganglion, a lower cervical ganglion, an inferior cervical ganglion, an intramural ganglion, a splanchnic nerve, an esophageal plexus, a cardiac plexus, a pulmonary plexus, an anterior pulmonary plexus, a posterior pulmonary plexus, a celiac plexus, a hypogastric plexus, an inferior mesenteric ganglion, a celiac ganglion, and a superior mesenteric ganglion.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.